Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer

PURPOSE/OBJECTIVE(S): After taxane and anthracycline failure, no standard chemotherapy regimen is established in metastatic breast cancer (MBC). Capecitabine and cisplatin (XP) combination shows promising results in gastrointestinal cancer, but there are relatively scarce data in MBC. We reviewed th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jieun, Kim, Hyun Ho, Ro, Sang Mi, Yang, Ji Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325186/
https://www.ncbi.nlm.nih.gov/pubmed/28234911
http://dx.doi.org/10.1371/journal.pone.0171605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325186/
https://www.ncbi.nlm.nih.gov/pubmed/28234911
http://dx.doi.org/10.1371/journal.pone.0171605

Ejemplares similares